Search

Search Constraints

You searched for: Date 2015 Author/Creator Rubbert-Roth, Andrea

Search Results

1. Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Issue 1 (8th June 2015)

3. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Issue 7 (20th February 2015)